Viz.ai, a frontrunner in artificial intelligence (AI) powered disease detection and intelligent care coordination, has inked an exclusive agreement with the University of California, San Francisco (UCSF) to commercialize three AI algorithms. Developed by leading researchers at UCSF, these algorithms aim for the automated detection of cardiovascular diseases, including cardiac amyloidosis, pulmonary hypertension, and supraventricular […]
Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]
Biotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices – Acticor and Rivacor range of devices for treating heart arrhythmia or cardiac arrhythmias. The six new tachycardia solutions approved by the FDA are Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX and Acticor CRT-DX Bipolar. Biotronik is […]
